On 3 June, the National Pathology Imaging Co-Operative (NPIC), part of Leeds Teaching Hospital NHS Trust, hosted over 100 representatives at Nexus, Leeds to celebrate the achievements of their world leading partnership of the NHS, academia and industry. Close collaboration on clinical and research projects is already improving diagnostic pathology services for patients today and helping the public experience healthier futures tomorrow.
The event was officially opened by Antony Kildare, Chair of Leeds Teaching Hospitals NHS Trust, and Dr Colin Wilson, Deputy Director of Research Infrastructure at the Office for Life Sciences, who welcomed delegates and highlighted the importance of collaboration, innovation and digital pathology in improving patient outcomes and shaping the future of healthcare.
Throughout the day, delegates heard from national leaders in health data, life sciences and pathology, sharing insights on the future of digital and computational pathology, the opportunities presented by AI, and the importance of collaboration across sectors. Keynote speakers Dr Melanie Ivarsson, CEO of the Health Data Research Service and Prof. Sarah Coupland, president elect of the Royal College of Pathologists provided a fascinating glimpse into the future of health data and clinical diagnosis in the UK.
Ed Whiting, CEO of Leeds City Council introduced an industry session highlighting the important role Leeds has in the medical technology sector, and the Mayor of West Yorkshire, Tracy Brabin provided some inspirational closing remarks, emphasising the important contribution of NPIC and Leeds Teaching Hospitals NHS Trust to the health technology landscape.
Commenting on the event, Professor Darren Treanor, NPIC Programme Director said: “NPIC is helping to drive one of the world’s largest digital pathology networks. The Summit’s discussions highlighted the remarkable progress already achieved, including the digitisation of more than four million pathology images, the connection of over 400 pathologists across 16 NHS sites, and the development of a secure national infrastructure supporting cutting-edge cancer and pathology research.
A huge thank you to all speakers, delegates and partners who contributed to such an inspiring and thought-provoking event. Together, we are building the future of pathology” and accelerating improvements in patient outcomes through research, innovation and technology.
